Publication

Article

Pharmaceutical Technology

Pharmaceutical Technology, April 2023
Volume47
Issue 4
Pages: 12

Automated mRNA Synthesis Kit

Bio-Rad Laboratories StarBright Blue and StarBright Yellow dyes are conjugated to flow validated antibodies, supporting flow cytometry panel design in immunology design.

Telesis Bio’s BioXp Select mRNA Synthesis Kit

Telesis Bio’s BioXp Select mRNA Synthesis Kit

Telesis Bio’s BioXp Select mRNA Synthesis Kit enables on-demand, automated synthesis of messenger RNA (mRNA). Beginning from the user’s plasmid DNA, the kit can deliver results overnight, enabling researchers to optimize discovery workflows more quickly.

Building on the company’s prior mRNA synthesis kit, which builds mRNA up to 1.8 kb in length starting from a DNA sequence as input, the new kit allows users to enter the sequence or linearized plasmid. This automates the entire workflow, allowing users to generate the final synthetic mRNA product in hours. The product also provides options for modified nucleosides.

Telesis Bio

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Related Videos
A global supply chain map, visualizing the complex network of transportation routes and distribution centers | Image Credit: © venusvi - stock.adobe.com
Shortcut from point A to point B | Image Credit: © Olivier Le Moal - stock.adobe.com
Wooden blocks spelling TARIFFS are placed on a map of North America, specifically over the United States and Mexico | Image Credit: © Rokas - stock.adobe.com
Simona Guidi, Associate Director, ProPharma
Behind the Headlines, Episode 18
Drug Digest: Patient Preference Drives Solid Dosage Trends
Behind the Headlines, Episode 17
Related Content